Skip to main content
. 2024 Apr 24;10(2):e003850. doi: 10.1136/rmdopen-2023-003850

Figure 6.

Figure 6

Survival analyses with log-rank test revealed that patients with polymyositis/dermatomyositis-associated interstitial lung disease in different risk groups had distinct 1 year survival probabilities in the development cohort (A) and internal validation cohort (B).